The forecasted respiratory system medicine use in Türkiye shows a year-on-year increase: 119.7 units in 2024, 123.3 units in 2025, 126.9 units in 2026, 130.4 units in 2027, and 133.9 units in 2028 (Defined Daily Dosage per Thousand Persons per Day). The year-on-year growth percentages are as follows:
- 2025: 3.01%
- 2026: 2.92%
- 2027: 2.76%
- 2028: 2.68%
The average annual growth rate (CAGR) over these five years is approximately 2.84%.
Future trends to watch include the impact of aging population, regional healthcare policy shifts, environmental changes, and innovation in respiratory treatments which may influence medicine use dynamics. Monitoring these factors will be crucial for accurate future forecasting.
